Ke Gong, Zhiping Tan, Haidan Liu, et al. A novel mutation of glycogen synthase kinase-3β leads to a reduced level of GSK3β protein in a patient with dilated cardiomyopathy. [J]. Genes & Diseases 1(1):84-86(2024)
DOI:
Ke Gong, Zhiping Tan, Haidan Liu, et al. A novel mutation of glycogen synthase kinase-3β leads to a reduced level of GSK3β protein in a patient with dilated cardiomyopathy. [J]. Genes & Diseases 1(1):84-86(2024) DOI: 10.1016/j.gendis.2023.02.040.
A novel mutation of glycogen synthase kinase-3β leads to a reduced level of GSK3β protein in a patient with dilated cardiomyopathy
摘要
Abstract
关键词
Keywords
references
1 R.G. Weintraub, C. Semsarian, P. MacDonaldDilated cardiomyopathy Lancet, 390 (10092) (2017), pp. 400-414
2 A.K. Sharma, P.V. Thanikachalam, S. BhatiaThe signaling interplay of GSK-3β in myocardial disorders Drug Discov Today, 25 (4) (2020), pp. 633-641
3 B.W. Doble, S. Patel, G.A. Wood, et al.Functional redundancy of GSK-3 alpha and GSK-3 beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines Dev Cell, 12 (6) (2007), pp. 957-971
4 M.J. Stachowski-Doll, M. Papadaki, T.G. Martin, et al.GSK-3β localizes to the cardiac Z-disc to maintain length dependent activation Circ Res, 130 (6) (2022), pp. 871-886